Pacific Biosciences OF California, Inc. (PACB) stock forecast and price target
Price $1.96 · data as of November 13, 2026
12-month price target
Average target$2.74
Upside / downside+39.9%
Analysts7
ConsensusBuy
Low $2.00Average $2.74High $3.00
Gold marker: average target · white marker: today’s price ($1.96)
Analyst ratings
Strong buy 0Buy 4Hold 3Sell 0Strong sell 1
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.49 | +7.7% | $157M |
| Next fiscal year ends December 31, 2027 | $-0.40 | +18.0% | $178M |
| Next quarter ends December 31, 2026 | $-0.12 | −2.1% | $41M |
| Quarter after ends March 31, 2027 | $-0.10 | +14.7% | $41M |
Consensus of the analysts covering Pacific Biosciences OF California, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Pacific Biosciences OF California stock price target?
The average 12-month target from 7 analysts is $2.74, 39.9% above the current price of $1.96 Targets range from $2.00 to $3.00.
Is Pacific Biosciences OF California a buy according to analysts?
The consensus rating is “Buy” (4 buy, 3 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Pacific Biosciences OF California expected to earn?
Analysts expect EPS of $-0.49 for the fiscal year ending December 31, 2026 and $-0.40 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.